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Abstract
Objectives: The main goal of the study was to assess possible association between fetal exposure to fine particulate mat-
ter (PM2.5) and exhaled carbon monoxide (eCO) measured in non-asthmatic children. Material and Methods: The sub-
jects include 118 children taking part in an ongoing population-based birth cohort study in Kraków. Personal samplers 
of PM2.5 were used to measure fine particle mass in the fetal period and carbon monoxide (CO) in exhaled breath from 
a single exhalation effort at the age of 7. In the statistical analysis of the effect of prenatal PM2.5 exposure on eCO, a set 
of potential confounders, such as environmental tobacco smoke (ETS), city residence area, sensitization to house dust 
allergens and the occurrence of respiratory symptoms monitored over the seven-year follow-up was considered. Results: 
The level of eCO did not correlate with the self-reported ETS exposure recorded over the follow-up, however, there was 
a positive significant relationship with the prenatal PM2.5 exposure (non-parametric trend p = 0.042). The eCO mean level 
was higher in atopic children (geometric mean = 2.06 ppm, 95% CI: 1.58–2.66 ppm) than in non-atopic ones (geometric 
mean = 1.57 ppm, 95% CI: 1.47–1.73 ppm) and the difference was statistically significant (p = 0.036). As for the respiratory 
symptoms, eCO values were associated positively only with the cough severity score recorded in the follow-up (nonparamet-
ric trend p = 0.057). In the nested multivariable linear regression model, only the effects of prenatal PM2.5 and cough sever-
ity recorded in the follow-up were related to eCO level. The prenatal PM2.5 exposure represented 5.1%, while children’s 
cough represented only 2.6% of the eCO variability. Conclusion: Our study suggests that elevated eCO in non-asthmatic 
children may result from oxidative stress experienced in the fetal period and that heme oxygenase (HO) activity in body 
tissues may be programmed in the fetal period by the exposure to fine particulate matter.
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caused by the exposure to diesel exhaust particulates [18]. 
The ambient fine particles are virtually always present in 
particle-generating processes, especially combustion pro-
cesses that generate other toxic agents as well. Typically, 
the ambient fine-particle fractions contain constituents of 
tobacco, organic compounds, sulfates, polycyclic aromatic 
hydrocarbons, metals and many other chemicals [19].
While most of the studies were concerned with the impor-
tance of eCO for clinical diagnosis or various other respi-
ratory disorders in adults and children, there is a scarcity 
of studies in humans about the potential effect of ambient 
pollutants on exhaled CO as a potential marker of oxida-
tive stress. The present study was done to assess the hy-
pothesis that the prenatal PM2.5 exposure may increase 
and program HO activity level in the vulnerable fetal pe-
riod and lead to higher eCO values in later life. As the 
asthmatic children may have symptomatic or subclinical 
airway inflammation associated with elevated eCO level, 
the study has been limited to non-asthmatic children who 
were free from current respiratory symptoms one month 
prior to eCO measurements. In the statistical evaluation 
of the effect caused by the fetal PM2.5 exposure on eCO 
in 7-year olds, a set of potential confounders, such as en-
vironmental tobacco smoke (ETS), city residence area, 
atopy, history of respiratory symptoms, such as cough, 
wheezing and difficult breathing regularly monitored from 
birth of children was accounted for. 
MATERIAL AND METHODS
The subjects include 118 children selected from the group 
of 132 children at the age of 7 who attended eCO testing 
and are participants of an ongoing longitudinal study on 
the health impact of prenatal exposure to outdoor/indoor 
air pollution in infants and children from the Kraków 
inner city area (principal investigator of the study is Prof. 
Perera from Columbia Center for Children’s Environmen-
tal Health, Mailman School of Public Health, Columbia 
INTRODUCTION
Exhaled carbon monoxide (eCO) measurements have ini-
tially been used for the assessment of ambient exposure 
to CO and tobacco smoking; however, it was found later 
that CO is also formed within the body irrespective of the 
environmental exposure [1,2]. Furthermore, it was ob-
served that under physiological conditions CO is present 
in measurable concentrations in the exhaled air of healthy 
individuals, and its levels may be elevated in numerous in-
flammatory states. Increased eCO levels have been found 
in the patients with asthma during the periods of non-ste-
roid therapy and asthma exacerbations, [3,4] during upper 
and lower respiratory infections [5–8], and in atopic sub-
jects as a result of allergen challenge [9–11]. 
Enzymatic degradation of heme and non-heme-related 
release (lipid peroxidation, xenobiotics, bacteria) are two 
major sources of endogenous CO. The predominant en-
dogenous source of CO (about 85%) in the body is from 
the degradation of hemoglobin by the enzyme heme 
oxygenase (HO) and the rest arises from degradation of 
myoglobin, catalase, Nitric Oxide synthase, guanylyl syn-
thase, and cytochromes [12,13]. Endogenous CO does not 
undergo further metabolism in the body, and as a gas se-
creted by lungs can be measured in exhaled breath from 
a single exhalation effort. 
The observed association between the increased expres-
sion of the inducible isoform (HO-1) in alveolar macro-
phages and higher levels of exhaled CO in asthmatic sub-
jects led to the hypothesis that eCO may be a biomarker 
of heme oxygenase (HO) enzyme activity within the respi-
ratory tract, which reflects oxidative stress-related bron-
chial inflammation [14–16]. However, further studies have 
shown that HO may be induced also in other body tissues 
by cellular oxidative stress, which is a key mechanism of 
the adverse health effects attributed to metal–generated 
free radicals, fine particulate matter and organic com-
pounds [17]. Recent studies have confirmed that CO in 
the expired air is a very sensitive marker of oxidative stress 
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expired air trapped over the sensor (lowest limit of detec-
tion 1 ppm) in a one-way valve. 
The measurement is non invasive, requires little tech-
nical expertise and is easy to perform in older children. 
The measurements were performed only in children who 
were free from any chest symptoms, rhinitis or eczema 
one month prior to the examination and were not on any 
medical therapy. On three consecutive occasions children 
were asked to inhale in the morning ambient air to near 
total lung capacity and exhale through a mouthpiece into 
the device for 15 seconds at a constant exhalation flow 
rate (50 ml/s). Exhaled CO was detectable in all children. 
Out of three expiratory efforts performed by a child the 
highest value was considered in the analysis. Expired CO 
concentrations measured by the Bedfont EC50 analyzer 
were found to correlate closely with blood carboxyhemo-
globin [21,22]. 
Dosimetry of fine particulate matter 
A Personal Environmental Monitoring Sampler (PEMS) 
developed by the Department of Environmental Health 
at Harvard University (Dr. John D. Spengler) was used to 
measure fine particle mass. A member of the air monitor-
ing staff instructed the women on how to use the personal 
monitor, which is lightweight and silent device worn in 
a small backpack. They were asked to wear the monitor 
during daytime hours for 2 consecutive days and place the 
monitor near their bed at night. 
The PEMS was designed to acquire the particle target 
size of ≤ 2.5 μm at a flow rate of 2.0 l/min (LPM). Flow 
rates were calibrated (with filters in place) using a bubble 
meter prior to the monitoring, and were checked again at 
the change of the battery pack on the second day and at 
the conclusion of the monitoring after a 48-hour period. 
The particles were collected on a Teflon membrane fil-
ter (37 mm Teflo™, Gelman Sciences). The combination 
of low-pressure drop (permitting the use of a low power 
sampling pump), low hygroscopicity (minimizing bound 
University, New York, US). The selected children were 
non-asthmatic, term born (> 36 weeks of gestation) and 
took part in all regular health check-ups in the follow-up 
period. The detailed description of the study design was 
presented elsewhere [20]. In short, pregnant women were 
recruited from ambulatory prenatal clinics in the first or 
second trimester of pregnancy. The study included women 
between 18 and 35 years of age, who claimed to be non-
smokers, with singleton pregnancies, without illicit drug 
use and HIV infection, free from chronic diseases such as 
diabetes or hypertension, and residents of Kraków for at 
least one year prior to pregnancy. All women participating 
in the study had read and signed informed consent. The 
Jagiellonian University Ethical Committee approved the 
research.
Upon enrollment, a detailed questionnaire was admin-
istered to each subject to obtain information on demo-
graphic data, house characteristics, medical history of 
mothers, and smoking practices of others present in the 
home. Over the seven-year follow-up, regular data on the 
occurrence of respiratory diseases and symptoms, such 
as cough, difficult breathing, wheezing spells and their 
duration were collected by interviewers visiting homes 
of children at intervals of 3 months in the first two years 
of life and every 6 months later. Environmental tobacco 
smoke (ETS) was assumed, if at least one of the house-
hold members was an active smoker over the follow-up 
period. Atopic status of children was defined as the sen-
sitization to at least one common aeroallergen (Der f1, 
Der p1, Can f1 and Fel d1) measured by the skin prick 
testing (SPT) at the age of 5 years. 
Exhaled CO measurements
Levels of exhaled carbon monoxide (eCO) were assessed 
by the new electronic portable battery-operated Bedfont 
EC50 analyzer (Bedfont Technical Instruments Ltd. Sit-
tingbourne UK) designed to measure end-expired (alveo-
lar) CO. The instrument samples CO by diffusion from 
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symptoms in days) was scored in tertiles of their distribu-
tions and atopy as a nominal variable. This nested regres-
sion model tests the significance of independent variables 
entered in a hierarchical sequence, each step adding an-
other block (variable) in the model. The regressions are 
nested in the sense that the first block of variable(s) is 
nested in the second one since all regression predictors 
in the first model are included in the second. Similarly, 
the second regression coefficients are nested in the third 
regression model and so on. The procedure reports listing 
of the variables entered with each block and increments 
in R2 and whether these are statistically significant. After 
the last block is added, the table summarizes the change 
in R2 for each block of variables together with F test for 
its significance. The nested regression model is appropri-
ate to estimate the effect of main independent variable 
(exposure) on a given outcome after controlling for the 
background variables. In the regression model, only cases 
with complete set of covariates were considered. Statisti-
cal analyses were performed by using the statistical soft-
ware STATA version 12.1.
Results
In the study sample the geometric mean of eCO 
was 1.6 ppm (95% CI: 1.5–1.8) and 45% of subjects 
showed 1 ppm. There was no difference in the character-
istics of children grouped by the lowest detecting limit of 
eCO (Table 1) and the children attending and non-attend-
ing eCO testing, except for those with higher eCO levels 
who reported slightly more days with difficult breathing 
(Table 2).
The level of eCO did not correlate with the self-reported 
ETS exposure recorded over the follow-up or residence 
area, however, there was a positive significant relationship 
with the prenatal PM2.5 exposure categorized in tertiles 
(non-parametric trend p = 0.042). 
In atopic children (N = 21), the level of eCO was much 
higher (geometric mean = 2.06, 95% CI: 1.58–2.66) than 
water interference in mass measurements), and low trace 
element background (improving analytical sensitivity) of 
these filters makes them highly appropriate for personal 
particle sampling. 
Ascertainment of atopic status
At the age of 5, the children who attended the follow-up 
were invited to undergo SPT for 4 common domestic aero-
allergens (Dermatophagoides pteronyssinus, Dermatopha-
goides farinae, dog and cat hair). The results were read af-
ter 15 min by measuring the largest diameter of the wheal. 
Atopic statuses were ascertained as a wheal-reaching di-
ameter of 3 mm and greater than the histamine control. 
The participants were defined as atopic if they had at least 
one positive skin prick test. 
Statistical analysis
Statistical analysis was performed in order to assess a pos-
sible association between eCO measured in 7-year-olds 
and prenatal personal exposure to PM2.5. As the distri-
butions of eCO and PM2.5 were skewed, in the statistical 
analysis, we used lognormal-transformed values, which 
satisfactory normalized the distribution, and the levels 
were given as geometric mean values (average after log-
transformation, followed by back transformation) togeth-
er with 95% confidence intervals. In the initial univariate 
analysis the differences in continuous variables between 
groups were analyzed using one-way analysis of variance; 
differences in the frequencies of categorical variables were 
evaluated with Chi-square test. The descriptive univariate 
analysis was followed by the nested multivariable linear 
regression model, which explored the relationship be-
tween the dependent variable (eCO log-transformed) and 
main exposure variable (prenatal PM2.5 log-transformed) 
and adjusted for a set of a priori selected covariates, 
such as severity of respiratory symptoms and atopic sta-
tus. The occurrence of respiratory symptoms monitored 
from the birth of children over the follow-up (duration of 
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associated positively only with the cough score (nonpara-
metric trend p = 0.057), but not with wheezing (p = 0.293) 
or difficult breathing (p = 0.758) scores.
Table 3 presents the results of the nested linear regression 
model of eCO (log-transformed values) on prenatal PM2.5 
exposure (log-transformed) respiratory symptoms and 
in non-atopic (geometric mean = 1.57, 95% CI: 1.47–
1.73) and the difference was statistically significant 
(p = 0.036). Interestingly, the prenatal PM2.5 did not cor-
relate with eCO level in the atopic children (Spearman 
rho = –0.321, p = 0.208). As for the respiratory symp-
toms reported in the follow-up, the level of the eCO was 
Table 1. Characteristics of children included in the analyses grouped by the median level of exhaled CO
Variables
Lowest detectable 
level of eCO  
(≤ 1 ppm) 
(N = 53)
n (%)
Higher level of eCO 
(> 1 ppm) 
(N = 65)
n (%)
Total 
(N= 118)
n (%)
p for difference
Gender of child: boys 26 (49.1) 36 (55.4) 62 (52.5) 0.6175
Maternal atopy: yes 13 (24.5) 13 (20.0) 26 (22.0) 0.7136
ETS 
0
1–3
38 (82.6)
6 (13.0)
46 (73.0)
9 (14.3)
84 (77.1)
15 (13.8)
0.3060
> 3 2 (4.3) 8 (12.7) 10 (9.2)
missing data 7 2 9
PM2.5 (in tertiles) (μg/m
3)
≤ 26.0 19 (35.8) 18 (27.7) 37 (31.4) 0.2092
26.1–38.0 18 (34.0) 17 (26.2) 35 (29.7)
> 38.0 16 (30.2) 30 (46.2) 46 (39.0)
Cough days 
0–101 16 (34.8) 16 (25.4) 32 (29.4) 0.4884
102–214 21 (45.7) 30 (47.6) 51 (46.8)
≥ 215 9 (19.6) 17 (27.0) 26 (23.9)
missing data 7 2 9
Wheezing days 
0 29 (63.0) 33 (52.4) 62 (56.9) 0.5207
1–12 12 (26.1) 20 (31.7) 32 (29.4)
≥ 13 5 (10.9) 10 (15.9) 15 (13.8)
missing data 7 2 9
Difficult breathing 
0 24 (52.2) 26 (41.3) 50 (45.9) 0.3545
1–13 11 (23.9) 23 (36.5) 34 (31.2)
≥ 14 11 (23.9) 14 (22.2) 25 (22.9)
missing data 7 2 9
ETS – environmental tobacco smoke, PM2.5 – particulate matter.
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contributed by 5.1% in explaining the eCO variability, 
children’s cough contributed a little less (2.6%). Figure 1 
shows the dose-dependent relationship between eCO lev-
els and prenatal PM2.5 exposure in children grouped by the 
cough scores. 
atopy. It was revealed that only the effects of PM2.5 and 
cough remained significant. The interaction term be-
tween both covariates was insignificant. The covariates 
considered in the regression model explained 9.5% of the 
total eCO variability. While the prenatal PM2.5 exposure 
Table 2. Characteristics of children under study grouped by the attendance to CO measurements
Variables
Attending 
(N = 132)
n (%)
Non-attending  
(N = 168)
n (%)
Total 
(N = 300)
n (%)
p for difference
Gender of child: boys 71 (53.8) 78 (46.4) 149 (49.7) 0.2505
Atopy: yes
missing data
17 (14.9) 
18
17 (14.0) 
47
34 (14.5) 
65
0.9981
Maternal atopy: yes 28 (21.2) 40 (23.8) 68 (22.7) 0.6932
PM2.5 (μg/m
3) 
mean 40.482 43.067 41.926 0.4173
standard deviation 25.982 28.351 27.316
missing data 0 1 1
ETS 
0 94 (77.0) 118 (73.3) 212 (74.9) 0.5193
1–3 18 (14.8) 23 (14.3) 41 (14.5)
> 3 10 (8.2) 20 (12.4) 30 (10.6)
missing data 10 7 17
Cough days 
0–101 33 (27.0) 38 (23.6) 71 (25.1) 0.6524
102–214 57 (46.7) 84 (52.2) 141 (49.8)
≥ 215 32 (26.2) 39 (24.2) 71 (25.1)
missing data 10 7 17
Wheezing days 
0 65 (53.3) 76 (47.2) 141 (49.8) 0.1686
1–12 34 (27.9) 39 (24.2) 73 (25.8)
≥ 13 23 (18.9) 46 (28.6) 69 (24.4)
missing data 10 7 17
Difficult breathing 
0 55 (45.1) 54 (33.5) 109 (38.5) 0.0901
1–13 37 (30.3) 51 (31.7) 88 (31.1)
≥ 14 30 (24.6) 56 (34.8) 86 (30.4)
missing data 10 7 17
Abbreviations the same as in Table 1.
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DISCUSSION
The study provided evidence that individual variability 
of eCO values in children may be related to the respi-
ratory symptoms and fetal exposure to fine particulate 
matter. The children who underwent eCO testing in our 
study did not present any current respiratory symptoms 
for one month before testing and were non-asthmatic. 
Except for the history of coughing, neither the severity 
of wheezing nor difficult breathing monitored over the 
follow-up since birth were significantly associated with 
exhaled CO levels. 
Table 3. Summary of hierarchical regression analysis for variables predicting eCO values (log-transformed) in 7-year olds (N = 107)*
Variables B coeff. SE B p level R-square Change in R-square
F for change in 
R-square
Model I
prenatal PM2.5 exposure 0.190 0.080 0.019 0.051 3.64
p = 0.019
Model II
prenatal PM2.5 exposure 0.193 0.080 0.018 0.058 0.007 0.75
p = 0.389wheezing score 0.044 0.051 0.389
Model III
prenatal PM2.5 exposure 0.202 0.080 0.013 0.084 0.026 2.94
p = 0.089wheezing score 0.029 0.052 0.567
cough score 0.094 0.055 0.090
Model IV
prenatal PM2.5 exposure 0.204 0.080 0.012 0.086 0.002 0.26
p = 0.609wheezing score 0.038 0.054 0.484
cough score 0.097 0.055 0.082
difficult breathing score –0.029 0.057 0.509
Model V
prenatal PM2.5 exposure 0.177 0.085 0.039 0.095 0.009 0.98
p = 0.324wheezing score 0.036 0.054 0.510
cough score 0.094 0.055 0.093
difficult breathing score –0.026 0.057 0.637
atopy 0.126 0.127 0.324
* Respiratory symptom scores for cough, wheezing and difficult breathing were based on the occurrence of symptoms recorded 
in the seven-year follow-up.
SE B – standard error of B coefficient, PM2.5 – particulate matter.
Fig. 1. Trends of eCO values vs. the prenatal PM2.5 exposure 
(ln-transformed) in children grouped by the cough scores 
recorded in the follow-up (linear regression fitting)
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to those in age-matched healthy non-smokers [6]. More-
over, elevated eCO levels were reported in asymptomatic 
but atopic individuals. For instance, Horvath et al. [9] in 
healthy non-smoking asymptomatic atopic adults compared 
with non-atopic individuals also demonstrated significantly 
elevated eCO values (4.7±0.3 ppm vs. 2.8±0.2 ppm). On 
average, eCO levels measured in our population sample 
exposed to prenatal PM2.5 levels were similar to those ob-
served in nonsmoking adults and healthy asymptomatic 
children reported from the Horvath studiy quoted above. 
The biological mechanisms whereby eCO might be ex-
plained by the prenatal PM2.5 exposure are not yet clear 
enough. PM2.5 is a proxy of a wide spectrum of environmen-
tal hazards that may be involved in generating oxidative 
stress [17–19]. It is important to mention that fine particles 
containing very high proportion of organic carbon has rel-
evance to the biologic potency of these particles, which is 
strongly correlated with the PAH content and oxidative 
stress inducing HO activity in body tissues. Many studies 
provided evidence that HO plays a key role in maintaining 
cellular and tissue homeostasis and has a potential antioxi-
dant and cytoprotective effect, which is linked with the an-
tioxidative function of end-products of heme degradation, 
such as CO or bilirubin [12,28]. However, it is likely that 
the excessive production of endproducts of heme degrada-
tion by HO may lead to the tissue damage. 
Epigenetic studies examining gene–air pollution exposure 
interactions may shed more light on the biological mecha-
nisms by which air pollution affects human health. A new 
hypothesis suggests that a greater susceptibility to air pol-
lutants may be linked with genomic polymorphism [29] 
and reduced levels of DNA methylation associated with 
oxidative stress, by altering the expression of genes in-
volved in the methylation process. In the context of poten-
tial epigenetic effects of air pollutants, we have to mention 
observations made recently by Perera et al. [30] in the New 
York City cohort study on fetal growth and healthy devel-
opment of children. In the latter study, prenatal exposure 
It is worth mentioning that the observed dose-dependent 
relationship without threshold was seen between eCO and 
fetal exposure to PM2.5 and that the significant portion 
of the exhaled CO could be attributed to prenatal PM2.5 
exposure. This could be explained by upgraded heme 
oxygenase activity possibly induced by the prenatal 
exposure to fine particulates in fetal body tissues might 
persist later in life and lead to the increased excretion 
of CO by alveoli. The reason to consider alveoli as the main 
site of exhaled CO is based on the observation that levels 
of CO measured at the end of exhalation are similar to 
those sampled by bronchoscope from the main bronchus. 
Exhaled CO levels are not flow-dependent, and highest CO 
levels are seen close to the end of exhalation [23–25]. 
However, a small proportion of eCO in the children with 
the history of coughing recorded in the follow-up, might 
have been produced in the upper airways and transported 
to the lower respiratory tract or reflect an enhanced CO 
production in the lower airways due to an ongoing 
subclinical inflammation. An alternative interpretation is 
that the prenatal exposure to fine particulate matter may 
be a proxy for the current exposure to the environmental 
factors implicated in generating oxidative stress, which 
might be the reason for the increased eCO levels. 
The mean exhaled CO levels observed in our study sam-
ple were lower than those observed in asthmatic chil-
dren and in patients with other respiratory disorders. 
Uausuf et al. [26] found eCO levels significantly higher 
(2.17±0.21) in children with persistent asthma compared 
to those with sporadic episodic asthma (1.39±0.18) and 
healthy children (1.01±0.12 ppm). As shown by Zayasu 
et al. [27] asthmatic adults had eCO concentrations still 
higher (5.6±0.6 ppm) compared to nonsmoking healthy 
control subjects (1.5±0.1 ppm). However, non-asthmatic 
subjects with the symptoms of upper respiratory tract infec-
tions also presented eCO levels significantly elevated dur-
ing the acute phase of the infection compared to recovery 
values (5.6±0.4 ppm vs. 1.0±0.1 ppm), which were similar 
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result from oxidative stress experienced in the fetal period, 
and that HO activity in body tissues may be programmed in 
the fetal period by the exposure to fine particulate matter. 
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to polycyclic aromatic hydrocarbons (PAHs) was signifi-
cantly associated with genomic hypomethylation in cord 
blood white cell’s DNA and showed the potential for epi-
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